Efficacy News and Research

RSS
Study indicates efficacy of antidepressants varies significantly depending on symptom severity

Study indicates efficacy of antidepressants varies significantly depending on symptom severity

IBI initiates Phase 2/3 pivotal clinical trial to assess the safety and efficacy of IBI-10090

IBI initiates Phase 2/3 pivotal clinical trial to assess the safety and efficacy of IBI-10090

Quercetin may prevent hepatitis C infection; findings may lead to less toxic treatments

Quercetin may prevent hepatitis C infection; findings may lead to less toxic treatments

IME introduces new drug-free pain relief alternative for headache

IME introduces new drug-free pain relief alternative for headache

Enrollment for sham-controlled study of radiation therapy for treatment of wet AMD announced

Enrollment for sham-controlled study of radiation therapy for treatment of wet AMD announced

ARYx Therapeutics receives guidance in writing from FDA on tecarfarin

ARYx Therapeutics receives guidance in writing from FDA on tecarfarin

Phase 2 study evaluating VBL Therapeutics' lead compound VB-201 initiated

Phase 2 study evaluating VBL Therapeutics' lead compound VB-201 initiated

Author evaluates potential benefits of IAD for treating prostate cancer

Author evaluates potential benefits of IAD for treating prostate cancer

Study shows increasing number of U.S. adults are taking antidepressants and antipsychotic medications

Study shows increasing number of U.S. adults are taking antidepressants and antipsychotic medications

Coformulation of rilpivirine and Truvada HIV drugs will achieve sales of more than $2 billion in 2018

Coformulation of rilpivirine and Truvada HIV drugs will achieve sales of more than $2 billion in 2018

Significant opportunity for alternative ulcerative colitis biological therapy

Significant opportunity for alternative ulcerative colitis biological therapy

New chemoprevention therapy for skin cancer

New chemoprevention therapy for skin cancer

Peginterferon alpha-2a yields better results in treating patients with chronic hepatitis C

Peginterferon alpha-2a yields better results in treating patients with chronic hepatitis C

Positive results from Pearl Therapeutics' PT005 Phase 2a trial for COPD

Positive results from Pearl Therapeutics' PT005 Phase 2a trial for COPD

Elusys Therapeutics signs contract to complete the final development of Anthim

Elusys Therapeutics signs contract to complete the final development of Anthim

NeoPharm submits IL13-PE38QQR IND for the treatment of IPF

NeoPharm submits IL13-PE38QQR IND for the treatment of IPF

Headline results from first phase III study of Balaglitazone announced

Headline results from first phase III study of Balaglitazone announced

DSPA submits lurasidone NDA to the FDA

DSPA submits lurasidone NDA to the FDA

Revance Therapeutics closes $35 million Series D financing

Revance Therapeutics closes $35 million Series D financing

Novelos continues NOV-002 Phase 3 combination trial for lung cancer

Novelos continues NOV-002 Phase 3 combination trial for lung cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.